Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
19 Dec 2025 Job Information Organisation/Company Radboud University Medical Center (Radboudumc) Research Field Engineering » Biomedical engineering Engineering » Electrical engineering Medical
-
applied to improving disease resistance. This postdoc project is part of the Gravitation program, GreenTE (Green Tissue Engineering), a multidisciplinary consortium of 7 Dutch universities. Together
-
the impact of trauma on local tissue perfusion. The lab also investigates spinal stimulation for chronic spinal cord injury and the use of stem cells and specialized polymers to improve recovery following
-
DWI-Leibniz-Institute für Interaktive Materialien e.V. | Aachen, Nordrhein Westfalen | Germany | about 2 months ago
to develop further both professionally and personally in an interdisciplinary setting. Position The DWI is looking for a Postdoctoral researcher to develop new granular biomaterials for tissue engineering
-
investigators, graduate students, and staff regarding health concerns, and / or husbandry issues; provides technical services for investigators including blood and tissue collection and anesthetic induction
-
, biological, or medical sciences field, or education in a related field considered equivalent to these qualifications. Documented experience and knowledge of cell biology, bioprinting, tissue engineering
-
28 Nov 2025 Job Information Organisation/Company University of Aveiro Department CICECO - Aveiro Institute of Materials Research Field Chemistry Chemistry » Biochemistry Engineering » Materials
-
Knowledge and skills in formulation and characterization of polymeric materials and composites Skills in additive manufacturing Desired requirements Knowledge and experience in tissue engineering Skills in in
-
every level of biological organization: genes, metabolism, cells, blood, tissues, organs, etc. It is implicated in 80+ autoimmune diseases, 400+ primary immune disorders, thousands of immune-inducing
-
engineer (IR) for a 12-month period, aims to develop a new generation of anticancer drugs called degraders (PROteolysis TArgeting Chimeras, PROTACs). These innovative molecules do not simply block a target